发明授权
- 专利标题： Vaccine protection assay
- 专利标题（中）： 疫苗保护试验
-
申请号： US11469204申请日： 2006-08-31
-
公开(公告)号： US07955817B2公开(公告)日： 2011-06-07
- 发明人: Isabel De Vleeschauwer , Nathalie Durant , Jan Poolman , Vincent Weynants
- 申请人： Isabel De Vleeschauwer , Nathalie Durant , Jan Poolman , Vincent Weynants
- 申请人地址： BE Rixensart
- 专利权人： GlaxoSmithKline Biologicals S.A.
- 当前专利权人： GlaxoSmithKline Biologicals S.A.
- 当前专利权人地址： BE Rixensart
- 代理商 Virginia G. Campen
- 优先权： EPPCT/EP05/09566 20050905
- 主分类号： C12Q1/18
- IPC分类号： C12Q1/18
摘要：
The present invention relates to the field of Serum Bactericidal Activity (SBA) assays for Gram negative bacteria, in particular N. meningitidis. The SBA assay is the most important method for measuring functional activity of serum antibodies against meningococcus. In order to determine whether a subject or a population is seropositive against invasive meningococcus the SBA test should ideally be both sensitive and specific. The inventors have found the standard N. meningitidis serotype A and W SBAs can be significantly improved in this regard.
公开/授权文献
- US20080064057A1 Vaccine Protection Assay 公开/授权日：2008-03-13
信息查询
